Moderna reinstated with an Underperform at BofA
BofA reinstated coverage of Moderna (MRNA) with an Underperform rating and $41 price target calling it “a tough time to be a ...
bovnews10h
Moderna Inc (MRNA) Stock Price Reaches $41.51: What Factors Are Influencing This Level?
On Tuesday, Moderna Inc (MRNA) stock saw a decline, ending the day at $41.51 which represents a decrease of $-4.14 or -9.07% from the prior close of $45.65. The stock opened at $45.36 and touched a ...
Alert on 3 Stocks on Sale
BofA (BAC) analysts restarted their coverage on 11 large-capitalization pharmaceutical and biotech firms. The bad news was ...
Wall Street Lunch: CPI 'On The Sticky Side' For November
CPI data matched expectations; Goods inflation rose to its highest level since May 2023. Albertson’s terminates merger with ...
Hosted on MSN20h
S&P Futures Gain With U.S. Inflation Data in Focus
S&P 500 E-Mini futures (ESZ24) are trending up +0.10% this morning as investors awaited the all-important U.S. inflation ...
Hosted on MSN21h
S&P Futures Tick Higher as Key U.S. Inflation Report Looms
S&P 500 E-Mini futures (ESZ24) are trending up +0.10% this morning as investors awaited the all-important U.S. inflation ...
Duolingo downgraded to Neutral from Buy at BofA
BofA analyst Curtis Nagle downgraded Duolingo (DUOL) to Neutral from Buy with a $375 price target Pick the best stocks and maximize your ...
Inflation rises to 2.7% ahead of the Federal Reserve's last meeting of 2024
Inflation accelerated slightly in November ahead of the Federal Reserve’s last interest rate decision of the year.